PB1762: PONATINIB VERSUS IMATINIB WITH REDUCED-INTENSITY CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME–POSITIVE (PH+) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): PH...

por Jabbour, E., Martinelli, G., Vignetti, M., Kantarjian, H., Gomez-Almaguer, D., Minami, Y., Dombret, H., Hennessy, M., Vorog, A., Wang, B., Ribera, J.-M.
Publicado 2022

Effect of using reporting guidelines during peer review on quality of final manuscripts submitted to a biomedical journal: masked randomised trial

por Cobo, E, Cortés, J, Ribera, J M, Cardellach, F, Selva-O’Callaghan, A, Kostov, B, García, L, Cirugeda, L, Altman, D G, González, J A, Sànchez, J A, Miras, F, Urrutia, A, Fonollosa, V, Rey-Joly, C, Vilardell, M
Publicado 2011

Epigenetic loss of the RNA decapping enzyme NUDT16 mediates C-MYC activation in T-cell acute lymphoblastic leukemia

por Anadón, C, van Tetering, G, Ferreira, H J, Moutinho, C, Martínez-Cardús, A, Villanueva, A, Soler, M, Heyn, H, Moran, S, Castro de Moura, M, Setien, F, Vidal, A, Genescà, E, Ribera, J M, Nomdedeu, J F, Guil, S, Esteller, M
Publicado 2017

Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia

por Gökbuget, N, Kelsh, M, Chia, V, Advani, A, Bassan, R, Dombret, H, Doubek, M, Fielding, A K, Giebel, S, Haddad, V, Hoelzer, D, Holland, C, Ifrah, N, Katz, A, Maniar, T, Martinelli, G, Morgades, M, O'Brien, S, Ribera, J-M, Rowe, J M, Stein, A, Topp, M, Wadleigh, M, Kantarjian, H
Publicado 2016

The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia

por Díaz-Beyá, M, Brunet, S, Nomdedéu, J, Cordeiro, A, Tormo, M, Escoda, L, Ribera, J M, Arnan, M, Heras, I, Gallardo, D, Bargay, J, Queipo de Llano, M P, Salamero, O, Martí, J M, Sampol, A, Pedro, C, Hoyos, M, Pratcorona, M, Castellano, J J, Nomdedeu, M, Risueño, R M, Sierra, J, Monzó, M, Navarro, A, Esteve, J
Publicado 2015

Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia

por Genescà, E., Lazarenkov, A., Morgades, M., Berbis, G., Ruíz-Xivillé, N., Gómez-Marzo, P., Ribera, J., Juncà, J., González-Pérez, A., Mercadal, S., Guardia, R., Artola, M. T., Moreno, M. J., Martínez-López, J., Zamora, L., Barba, P., Gil, C., Tormo, M., Cladera, A., Novo, A., Pratcorona, M., Nomdedeu, J., González-Campos, J., Almeida, M., Cervera, J., Montesinos, P., Batlle, M., Vives, S., Esteve, J., Feliu, E., Solé, F., Orfao, A., Ribera, J. M.
Publicado 2018

P1702: IMPACT OF CENTER CHARACTERISTICS AND MACROECONOMIC FACTORS ON THE OUTCOME OF ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH PEDIATRIC-INSPIRED PROTOCOLS

por Barba, P., Morgades, M., Montesinos, P., Gonzalez Campos, J., Torrent, A., Gil, C., Bernal, T., Tormo, M., Mercadal, S., Saumell, S., García-Cadenas, I., Queipo de Llano, M., Cervera, M., Coll, R., Bermudez, A., Amigo, M., Monsalvo, S., Esteve, J., Garcia Boyero, R., Novo, A., Hernandez Rivas, J., Cladera, A., Martinez-Sanchez, P., Serrano, J., Artola, M. T., Soria, B., Abella, E., Vall-Llobera, F., Bergua, J., Herrera, P., Barrios, D., Ribera, J. M.
Publicado 2022

Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus

por Buske, C., Dreyling, M., Alvarez-Larrán, A., Apperley, J., Arcaini, L., Besson, C., Bullinger, L., Corradini, P., Giovanni Della Porta, M., Dimopoulos, M., D’Sa, S., Eich, H.T., Foà, R., Ghia, P., da Silva, M.G., Gribben, J., Hajek, R., Harrison, C., Heuser, M., Kiesewetter, B., Kiladjian, J.J., Kröger, N., Moreau, P., Passweg, J.R., Peyvandi, F., Rea, D., Ribera, J.-M., Robak, T., San-Miguel, J.F., Santini, V., Sanz, G., Sonneveld, P., von Lilienfeld-Toal, M., Wendtner, C., Pentheroudakis, G., Passamonti, F.
Publicado 2022